Oxycodone and Pregabalin for the Treatment of Oncological Neuropathic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
CancerPain
Interventions
DRUG

oxycodone

"Arm A - 20 mg/day~Arm B - increasing dose startnig at 20 mg/day~For 15 days or until unacceptable toxicity develops."

DRUG

pregabalin

"Arm A - pregabalin at increasing dose starting from 50 mg/day~Arm B - pregabalin 50 mg/day~For 15 days or until unacceptable toxicity develops."

Trial Locations (8)

20015

Ospedale Civile di Legnano, Parabiago

20121

Fatebenefratelli and Ophtalmic Hospital, Milan

24123

Ospedali Riuniti, Bergamo

25122

Ospedale S. Orsola, Brescia

29964

Ospedale Serbelloni, Gorgonzola

37024

Ospedale Sacro Cuore, Negrar

82100

Ospedale Fatebenefratelli, Benevento

Unknown

Ospedale Fatebenefratelli, Roma

All Listed Sponsors
collaborator

Mario Negri Institute for Pharmacological Research

OTHER

lead

Associazione Progetto Oncologia UMAN.A

OTHER

NCT00637975 - Oxycodone and Pregabalin for the Treatment of Oncological Neuropathic Pain | Biotech Hunter | Biotech Hunter